Interventions for preventing silent cerebral infarcts in people with sickle cell disease

about

Selecting and implementing overview methods: implications from five exemplar overviews.Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.

P2860

Q33916672-FCC5FC30-5384-439E-9C07-49374B755D25 Q36251052-61BF1333-4638-478B-B045-34E26C9AB5AF

P2860

Interventions for preventing silent cerebral infarcts in people with sickle cell disease

Item

http://www.wikidata.org/entity/Q57689825

description

im Oktober 2016 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 01 October 2016

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2016

@uk

name

Interventions for preventing silent cerebral infarcts in people with sickle cell disease

@en

Interventions for preventing silent cerebral infarcts in people with sickle cell disease

@nl

type

Item

label

Interventions for preventing silent cerebral infarcts in people with sickle cell disease

@en

Interventions for preventing silent cerebral infarcts in people with sickle cell disease

@nl

prefLabel

Interventions for preventing silent cerebral infarcts in people with sickle cell disease

@en

Interventions for preventing silent cerebral infarcts in people with sickle cell disease

@nl

P1476

Interventions for preventing silent cerebral infarcts in people with sickle cell disease

@en

P2093

Carolyn Doree

http://www.w3.org/2001/XMLSchema#string

Miguel R Abboud

http://www.w3.org/2001/XMLSchema#string

Patricia M Fortin

http://www.w3.org/2001/XMLSchema#string

Sally Hopewell

http://www.w3.org/2001/XMLSchema#string

P2860

Hematopoietic stem cell transplantation for people with sickle cell disease

Silent cerebral infarcts: a review on a prevalent and progressive cause of neurologic injury in sickle cell anemia

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

Advances in sickle cell therapies in the hydroxyurea era

Practical methods for incorporating summary time-to-event data into meta-analysis

Etiology of strokes in children with sickle cell anemia.

Delayed hemolytic transfusion reaction in sickle cell disease

The co-inheritance of alpha-thalassemia and sickle cell anemia is associated with better hematological indices and lower consultations rate in Cameroonian patients and could improve their survival.

Discontinuing prophylactic transfusions increases the risk of silent brain infarction in children with sickle cell disease: data from STOP II.

P31

scholarly article

P356

10.1002/14651858.CD012389

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

2016

http://www.w3.org/2001/XMLSchema#string

P50

Marialena Trivella

Lise J Estcourt

P577

2016-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28344510

http://www.w3.org/2001/XMLSchema#string

P932

5360228

http://www.w3.org/2001/XMLSchema#string

Interventions for preventing silent cerebral infarcts in people with sickle cell disease

about

P2860

P2860

Interventions for preventing silent cerebral infarcts in people with sickle cell disease

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P407

P433

P478

P50

P577

P698

P932